The new service chief will report to the Deputy Division Head of Cellular Therapy and the Head of DHM, and will have programmatic oversight and responsibility for the service and faculty. This service will operate in a matrix reporting structure, with providers practicing in disease specific services, along with the Cellular Therapy Service. The service chief will work to shape the strategic and programmatic priorities for the service, clinical excellence, clinical operational efficiency, talent acquisition and retention, research, grant funding, professional development, mentorship and teaching. The administrative infrastructure available in the service will allow the service chief to maintain both a clinical practice and an independent research program.